# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA323217 | 31b | IC50 | = | 32.1 | uM | ALA805260 | 4.49 | nM | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | ||
2. | ALA3137913 | 14 | IC50 | = | 10.3 | uM | ALA805260 | 4.99 | nM | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | ||
3. | ALA108485 | 44 | IC50 | = | 21.4 | uM | ALA805260 | 4.67 | nM | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | ||
4. | ALA3137920 | 19 | IC50 | = | 8.4 | uM | ALA805260 | 5.08 | nM | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | ||
5. | ALA3137910 | 11 | IC50 | = | 3.6 | uM | ALA805260 | 5.44 | nM | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | ||
6. | ALA323490 | 43 | IC50 | = | 4.5 | uM | ALA805260 | 5.35 | nM | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | ||
7. | ALA320265 | 30b | IC50 | = | 72 | uM | ALA805260 | 4.14 | nM | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | ||
8. | ALA3138234 | 6 | IC50 | = | 24.5 | uM | ALA805260 | 4.61 | nM | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | ||
9. | ALA325765 | 38a | IC50 | = | 33.5 | uM | ALA805260 | 4.47 | nM | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | ||
10. | ALA209688 | 1b | Inhibition | = | 76.8 | % | ALA854586 | % | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | |||
11. | ALA209092 | 7l | Inhibition | = | 51.2 | % | ALA854586 | % | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | |||
12. | ALA207416 | 7j | Inhibition | = | 60 | % | ALA854586 | % | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | |||
13. | ALA207678 | 7f | Inhibition | = | 13.9 | % | ALA854586 | % | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | |||
14. | ALA67356 | 9b | Inhibition | = | 3.8 | % | ALA854586 | % | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | |||
15. | ALA207474 | 7g | Inhibition | < | 0 | % | ALA854586 | % | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | |||
16. | ALA379640 | 20d | Inhibition | = | 75.3 | % | ALA854586 | % | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | |||
17. | ALA213057 | 20b | Inhibition | = | 99.6 | % | ALA854586 | % | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | |||
18. | ALA377233 | 6i | Inhibition | = | 86.6 | % | ALA854586 | % | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | |||
19. | ALA302007 | 8f | Inhibition | = | 38.4 | % | ALA854586 | % | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | |||
20. | ALA304747 | 7a | Inhibition | = | 11.4 | % | ALA854586 | % | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) |